Osteonecrosis due to drugs of left ulna
ICD-10 M87.135 is a billable code used to indicate a diagnosis of osteonecrosis due to drugs of left ulna.
Osteonecrosis, also known as avascular necrosis, is a condition characterized by the death of bone tissue due to a lack of blood supply. In the case of M87.135, the osteonecrosis is specifically attributed to the use of certain medications, which can disrupt blood flow to the bone. The left ulna, one of the two long bones in the forearm, is affected in this diagnosis. Commonly implicated drugs include corticosteroids and bisphosphonates, which can lead to bone weakening and increased susceptibility to fractures. Patients may present with pain, swelling, and limited range of motion in the affected area. Diagnosis typically involves imaging studies such as MRI or X-rays, which can reveal changes in bone density and structure. Treatment options may include medication adjustments, physical therapy, or surgical interventions such as core decompression or joint replacement, depending on the severity of the condition. Understanding the underlying causes and appropriate management strategies is crucial for optimizing patient outcomes.
Detailed history of medication use, imaging results, and physical examination findings.
Patients presenting with joint pain and a history of corticosteroid use.
Ensure that the documentation specifies the affected bone and any prior treatments.
Comprehensive medication history and assessment of underlying conditions.
Patients with autoimmune disorders on long-term corticosteroid therapy.
Document any comorbidities that may contribute to osteonecrosis.
Used for pain management in patients with osteonecrosis.
Document the joint involved and the reason for the procedure.
Orthopedic specialists should ensure proper coding based on the joint treated.
Common drugs associated with osteonecrosis include corticosteroids, bisphosphonates, and certain chemotherapy agents. It's important to document the specific medication involved in the patient's history.
